USING AI AND NEUROIMAGING
ADVANCED CLINICAL TRIALS AND THERAPIES
OPTIMIZED THERAPIES
OPTIMAL MEASURES
Qynapse is a medical technology company, spin-off of the CATI consortium of neuroimaging research laboratories.
Qynapse is a medical technology company, spin-off of the CATI consortium of neuroimaging research laboratories.
NEWS
https://www.qynapse.com/wp-content/uploads/2019/07/AAIC2019.png
450
1050
Paul
https://www.qynapse.com/wp-content/uploads/2019/06/Qynapse_HD.png
Paul2019-07-01 15:58:502019-07-08 22:34:08Qynapse exhibits at the 2019 Alzheimer’s Association International Conference® (AAIC®) in Los Angeles, CA
https://www.qynapse.com/wp-content/uploads/2019/07/QyScore.png
300
700
Paul
https://www.qynapse.com/wp-content/uploads/2019/06/Qynapse_HD.png
Paul2019-04-11 23:07:192019-07-08 22:32:51Qynapse releases new validation results of QyScore® performance
https://www.qynapse.com/wp-content/uploads/2019/07/ADPD-1.png
450
1050
Paul
https://www.qynapse.com/wp-content/uploads/2019/06/Qynapse_HD.png
Paul2019-02-25 08:32:042019-07-11 10:08:47Qynapse attended the 14th AD/PD International Conference
https://www.qynapse.com/wp-content/uploads/2019/07/AGMednet-1.png
345
805
Paul
https://www.qynapse.com/wp-content/uploads/2019/06/Qynapse_HD.png
Paul2018-10-03 17:51:452019-07-08 22:26:55Qynapse partners with AG Mednet
Qynapse is a medical technology company that unlocks the potential of quantitative imaging and AI to optimize diagnosis, prognosis and longitudinal monitoring of patients with neurological diseases.
